Newsletter

Across clinical development, AI is quickly moving from a future-facing idea to a practical tool for improving efficiency, visibility, and decision-making.

‍

As interest grows, teams are asking more focused questions: where does AI fit, how should it be governed, what data can it safely access, and how should outputs be reviewed?

Thank you for continuing to be part of the Ascendia Clinical community. As we moved through Q2, one theme remained clear: sponsors and clinical teams are being asked to do more with greater precision, stronger oversight, and fewer delays.

‍

This quarter, our conversations focused on practical execution across clinical operations, quality, vendor oversight, and emerging technology. Teams are looking for ways to reduce complexity while maintaining control over the decisions that matter most.

‍

In this edition, we highlight key areas from Q2, including flexible support models, the experience behind Ascendia’s work, ongoing conversations from The Clinical Current, and the evolving role of AI in clinical operations.